Welcome!

News Feed Item

Patheon Reports Preliminary Unaudited First Quarter Fiscal 2014 Results

TORONTO, March 6, 2014 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, with recently acquired proprietary products, announced today preliminary unaudited fiscal 2014 first-quarter results. Based on its current expectations, Patheon anticipates the following results for its first-quarter ended January 31, 2014:

  • Revenues of approximately $266.7 million versus $213.5 million in the prior year.
  • Adjusted EBITDA of approximately $36.4 million versus $19.8 million in the prior year.
  • Loss from continuing operations of approximately $0.1 million versus a loss of $51.4 million in the prior year.

Because Patheon's results of operations for the first quarter of fiscal 2014 have not yet been finalized, the preliminary results included in this press release are subject to change as a result of the period-end closing process and review of Patheon's financial statements by its independent registered public accounting firm. See "Caution Concerning Forward Looking Statements and Preliminary Financial Results." All currency is expressed in U.S. dollars.

About Patheon
Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company's recent acquisition of Banner Pharmacaps - a market leader in soft gelatin capsule technology - Patheon now also includes a proprietary products and technology business. Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. Patheon's integrated network consists of 15 locations, including 12 commercial contract manufacturing facilities and 9 product development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit www.patheon.com.

Use of Non-GAAP Measures
This press release includes the financial measure Adjusted EBITDA that has not been prepared in accordance with accounting principles generally accepted in the United States ("GAAP").

"Adjusted EBITDA" is defined as loss from continuing operations before repositioning expenses, interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition and integration costs (including certain product returns and inventory write-offs recorded in gross profit), gains and losses on sale of capital assets, income taxes, asset impairment charges, depreciation and amortization, stock-based compensation expense, consulting costs related to Patheon's operational initiatives, purchase accounting adjustments, acquisition-related litigation expenses and other income and expenses. Readers are cautioned that Adjusted EBITDA should not be construed as an alternative to loss from continuing operations determined in accordance with U.S. GAAP as an indicator of performance. Adjusted EBITDA is used by management as an internal measure of profitability. Patheon has included Adjusted EBITDA because it believes that this measure is used by certain investors to assess its financial performance before non-cash charges and certain costs that it does not believe are reflective of its underlying business.

Since non-GAAP measures do not have a standardized meaning, they may not be comparable to similar measures presented by other issuers. Readers are cautioned that these non-GAAP measures are not based on any comprehensive set of accounting rules or principles and that they should be considered only in conjunction with, and not as a substitute for, or superior to, loss from continuing operations determined in accordance with GAAP as indicators of performance and not as a substitute for, or superior to, operating cash flow as an indicator of liquidity, as applicable. These non-GAAP measures are subject to inherent limitations because (i) they do not reflect all of the expenses and cash flow associated with loss from continuing operations and operating cash flow, respectively, determined in accordance with GAAP and (ii) the composition of these non-GAAP measures involved the exercise of judgment by management. A reconciliation of these non-GAAP measures to their closest U.S. GAAP measures is included in this press release.

Caution Concerning Forward-Looking Statements and Preliminary Financial Results

This press release contains forward-looking statements which reflect Patheon's expectations regarding its future growth, results of operations, performance (both operational and financial) and business prospects and opportunities. All statements, other than statements of historical fact, are forward-looking statements. Wherever possible, words such as "plans", "expects" or "does not expect", "forecasts", "anticipates" or "does not anticipate", "believes", "intends" and similar expressions or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved have been used to identify these forward-looking statements. Although the forward looking statements contained in this press release reflect Patheon's current assumptions based upon information currently available to it and based upon what Patheon believes to be reasonable assumptions, Patheon cannot be certain that actual results will be consistent with its expectations and other forward-looking statements. Forward-looking statements are provided in order to assist stakeholders in understanding management's expectations as of the date of this press release, and may not be suitable for other purposes. Patheon's current material assumptions include assumptions related to its operational excellence initiatives and transformation activities, customer volumes, regulatory compliance, foreign exchange rates, employee severance costs associated with termination, and projected integration savings related to the Banner acquisition. Forward-looking statements necessarily involve significant known and unknown risks, assumptions and uncertainties that may cause Patheon's actual results, performance, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, risks related to international operations and foreign currency fluctuations; customer demand for Patheon's services; regulatory matters affecting manufacturing and pharmaceutical development services; impacts of acquisitions, divestitures, restructurings and other strategic transactions (including Patheon's acquisition by JLL/Delta Patheon Holdings, L.P.) and Patheon's ability to achieve its intended objectives with respect to such transactions and to integrate businesses that it may acquire or combine with; implementation of Patheon's operational excellence initiatives and transformation activities; Patheon's ability to effectively transfer business between facilities; the global economic environment; Patheon's exposure to complex production issues; Patheon's substantial financial leverage; interest rate risks; potential environmental, health and safety liabilities; credit and customer concentration; competition; rapid technological change; product liability claims; intellectual property; the fact that Patheon has a majority shareholder that can exercise significant influence over it; supply arrangements; pension plans; derivative financial instruments; and Patheon's dependence upon key management, scientific and technical personnel. For additional information regarding risks and uncertainties that could affect Patheon's business, please see Item 1A "Risk Factors" of Patheon's Annual Report on Form 10-K/A (Amendment No. 1) for the fiscal year ended October 31, 2013 as further amended by Amendment No. 2 on Form 10-K/A, and its subsequent filings with the U.S. Securities and Exchange Commission ("SEC") and the Canadian securities regulators. Although Patheon has attempted to identify important risks and factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors and risks that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date of this press release and, except as required by law, Patheon assumes no obligation to update or revise them to reflect new events or circumstances.

In addition, Patheon is currently undergoing its quarter-end closing and review process. Because Patheon's results of operations for the quarter ended January 31, 2014 have not yet been finalized, the preliminary results included in this press release are subject to change as a result of the period-end closing process and the review of Patheon's financial statements by its independent registered public accounting firm, Ernst & Young LLP. These changes may be material. The preliminary financial results included in this press release have been prepared by, and are the responsibility of, Patheon's management. Ernst & Young LLP has not completed its review of Patheon's first quarter 2014 financial statements, and accordingly, Ernst & Young LLP does not express an opinion or any form of assurance with respect to these preliminary financial results. These preliminary financial results are not necessarily indicative of results of future operations. Accordingly, readers should not place undue reliance on Patheon's preliminary financial results. These preliminary financial results should be read in conjunction with Patheon's previously disclosed consolidated historical financial statements (and related notes).

Additional Information

On November 18, 2013, Patheon entered into an Arrangement Agreement (the "Arrangement Agreement") with JLL/Delta Patheon Holdings, L.P., ("Newco") under which Patheon would be taken private pursuant to a court-approved plan of arrangement under the Canada Business Corporations Act. This press release may be deemed to be proxy solicitation material in respect of this proposed transaction. Copies of the Arrangement Agreement, the proxy statement and management information circular for the Special Meeting (which includes the valuation and the fairness opinions obtained by Patheon in connection with the transaction) and certain related documents have been filed with Canadian and U.S. securities regulators and are available on the Canadian SEDAR profile of Patheon at www.sedar.com and the SEC's website (EDGAR) at www.sec.gov. In addition, investors and securityholders may obtain free copies of the documents Patheon files with the SEC and with Canadian securities regulators by directing a written request to Patheon Inc., 2100 Syntex Court, Mississauga, Ontario, Canada L5N 7K9, Attention: Corporate Secretary. Copies of Patheon's filings with the SEC and with Canadian securities regulators may also be obtained at the "Investor Relations" section of Patheon's website at www.patheon.com.

As noted above, Patheon has filed with the SEC, and on SEDAR, and furnished to its shareholders a proxy statement and management information circular in connection with the proposed transaction with Newco. Investors and securityholders of Patheon are urged to read the proxy statement and management information circular and the other relevant materials because such materials contain important information about Patheon, Newco and the proposed transaction.

Patheon and its directors and executive officers may be deemed to be participants in the solicitation of proxies from the securityholders of Patheon in connection with the proposed transaction. Information about Patheon and its directors and executive officers, including their ownership of Patheon securities, is set forth in the Annual Report (Form 10-K) which was filed with the SEC and on SEDAR on January 10, 2014, as amended by Amendment No. 1 on Form 10-K/A which was filed with the SEC and on SEDAR on January 13, 2014,  and as further amended by Amendment No. 2 on Form 10-K/A, which was filed with the SEC and on SEDAR on February 21, 2014, and as supplemented by other Patheon filings with the SEC and Canadian securities regulators. Investors and securityholders may obtain additional information regarding the direct and indirect interests of Patheon and its directors and executive officers in the proposed transaction by reading the proxy statement and management information circular and other public filings referred to above.

Patheon Inc.
CONSOLIDATED BALANCE SHEETS
(preliminary and unaudited)
         
         
    As of January 31,
2014
  As of October 31,
2013
(in millions of U.S. dollars)   $   $
         
Assets        
Current        
  Cash and cash equivalents    45.8   61.6
  Accounts receivable, net   180.9   191.3
  Inventories    143.5   137.8
  Income taxes receivable   4.0   3.6
  Prepaid expenses and other   12.1   15.3
  Deferred tax assets - short-term    6.1   6.1
Total current assets   392.4   415.7
         
Capital assets    484.4   496.7
Intangible assets    67.5   69.2
Deferred financing costs   19.3   20.2
Deferred tax assets    0.1   0.1
Goodwill   48.2   48.5
Investments   9.4   8.4
Other long-term assets    22.7   19.0
Total assets   1,044.0   1,077.8
         
Liabilities and shareholders' equity        
Current        
  Short-term borrowings   0.7   3.0
  Accounts payable and accrued liabilities   204.7   221.9
  Income taxes payable   2.3   0.1
  Deferred revenues - short-term   16.3   15.0
  Deferred tax liability - short-term   0.1   0.1
  Current portion of long-term debt    6.8   6.8
Total current liabilities   230.9   246.9
         
Long-term debt    603.0   599.2
Deferred revenues    19.4   20.1
Deferred tax liabilities    43.4   43.4
Other long-term liabilities   38.0   41.8
Total liabilities   934.7   951.4
         
Shareholders' equity        
  Restricted voting shares    610.6   610.6
  Contributed surplus    17.5   16.7
  Accumulated deficit   (514.6)   (514.5)
  Accumulated other comprehensive income   (4.2)   13.6
Total shareholders' equity   109.3   126.4
Total liabilities and shareholders' equity   1,044.0   1,077.8

 


Patheon Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(preliminary and unaudited)
     
     
  Three months ended January 31,
    2014   2013
(in millions of U.S. dollars, except loss per share)   $   $
         
Revenues    266.7   213.5
Cost of goods sold   197.8   171.1
Gross profit   68.9   42.4
Selling, general and administrative expenses    46.3   35.2
Research and development   2.8   1.3
Repositioning expenses    0.7   4.0
Acquisition and integration costs   4.9   4.4
Impairment charge    -   10.1
Gain on sale of fixed assets   (0.4)   (0.3)
Operating income (loss)   14.6   (12.3)
Interest expense, net   12.8   9.8
Foreign exchange loss, net   1.2   0.8
Refinancing expenses    -   29.1
Other income, net   (1.3)   (0.4)
Income (Loss) from continuing operations before income taxes   1.9   (51.6)
Provision for (benefit from) income taxes    2.0   (0.2)
Loss from continuing operations   (0.1)   (51.4)
Net loss attributable to restricted voting shareholders   (0.1)   (51.4)
         
Basic and diluted loss per share        
  From continuing operations   ($0.001)   ($0.384)
         
Weighted-average number of shares outstanding during period -
basic and diluted (in thousands)
  140,936   133,849

 

Patheon Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(preliminary and unaudited)
   
   
  Three months ended January 31,
       
  2014   2013
(in millions of U.S. dollars) $   $
       
Operating activities      
Loss from continuing operations (0.1)   (51.4)
  Add (deduct) charges to operations not requiring a current cash payment      
    Depreciation and amortization  12.4   11.0
    Impairment charge -   10.1
    Other non-cash interest 1.5   4.9
    Change in other long-term assets and liabilities (5.5)   (1.6)
    Deferred income taxes -   (1.0)
    Amortization of deferred revenues (5.1)   (4.2)
    Gain on sale of capital assets (0.4)   (0.3)
    Stock-based compensation expense 0.8   0.8
    Other (1.4)   0.1
  2.2   (31.6)
  Net change in non-cash working capital balances related to continuing operations  (17.3)   19.7
  Increase in deferred revenues 6.5   5.6
       
Cash used in operating activities (8.6)   (6.3)
       
Investing activities      
  Additions to capital assets (11.4)   (8.4)
  Proceeds on sale of capital assets 4.4   0.4
  Acquisitions, net of cash acquired -   (258.9)
       
Cash used in investing activities (7.0)   (266.9)
       
Financing activities      
  Proceeds from long-term borrowings 13.0   592.1
  Increase in deferred financing costs -   (21.7)
  Repayment of debt, net of penalty payment (12.2)   (315.8)
  Share issue cost  -   (0.9)
  Proceeds on issuance of restricted voting shares -   32.9
       
Cash provided by financing activities 0.8   286.6
       
Effect of exchange rate changes on cash and cash equivalents (1.0)   2.6
       
Net (decrease) increase in cash and cash equivalents during the period (15.8)   16.0
Cash and cash equivalents, beginning of period 61.6   39.4
           
Cash and cash equivalents, end of period 45.8   55.4
           

 

ADJUSTED EBITDA BRIDGE
(Preliminary and Unaudited)

     
     
    Three months ended January 31,
    2014   2013
(in millions of U.S. dollars)   $   $
Loss from continuing operations   (0.1)   (51.4)
Add (deduct):        
  Provision for (benefit from) income taxes   2.0   (0.2)
  Gain on sale of capital assets   (0.4)   (0.3)
  Acquisition and integration costs   4.9   4.4
  Refinancing expenses   -   29.1
  Interest expense, net   12.8   9.8
  Repositioning expenses   0.7   4.0
  Depreciation and amortization   12.4   11.0
  Impairment charge   -   10.1
  Operational initiatives related consulting costs   1.4   0.1
  Acquisition-related litigation expenses   3.1   -
  Stock-based compensation expense   0.8   0.8
  Purchase accounting adjustments   -   2.9
  Other   (1.2)   (0.5)
Adjusted EBITDA   36.4   19.8
             

 

 

 

SOURCE Patheon Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DXWorldEXPO LLC announced today that ICC-USA, a computer systems integrator and server manufacturing company focused on developing products and product appliances, will exhibit at the 22nd International CloudEXPO | DXWorldEXPO. DXWordEXPO New York 2018, colocated with CloudEXPO New York 2018 will be held November 11-13, 2018, in New York City. ICC is a computer systems integrator and server manufacturing company focused on developing products and product appliances to meet a wide range of ...
The taxi industry never saw Uber coming. Startups are a threat to incumbents like never before, and a major enabler for startups is that they are instantly “cloud ready.” If innovation moves at the pace of IT, then your company is in trouble. Why? Because your data center will not keep up with frenetic pace AWS, Microsoft and Google are rolling out new capabilities. In his session at 20th Cloud Expo, Don Browning, VP of Cloud Architecture at Turner, posited that disruption is inevitable for comp...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous ar...
Sanjeev Sharma Joins November 11-13, 2018 @DevOpsSummit at @CloudEXPO New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
Headquartered in Plainsboro, NJ, Synametrics Technologies has provided IT professionals and computer systems developers since 1997. Based on the success of their initial product offerings (WinSQL and DeltaCopy), the company continues to create and hone innovative products that help its customers get more from their computer applications, databases and infrastructure. To date, over one million users around the world have chosen Synametrics solutions to help power their accelerated business or per...
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new technologies can require relearning or adapting new, oftentimes more complex, methodologies and tools to be ready for production. In his general session at @DevOpsSummit at 20th Cloud Expo, Chris Brown, Solutions Marketi...
At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
HyperConvergence came to market with the objective of being simple, flexible and to help drive down operating expenses. It reduced the footprint by bundling the compute/storage/network into one box. This brought a new set of challenges as the HyperConverged vendors are very focused on their own proprietary building blocks. If you want to scale in a certain way, let's say you identified a need for more storage and want to add a device that is not sold by the HyperConverged vendor, forget about it...
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use of real time applications accelerate, legacy networks are no longer able to architecturally support cloud adoption and deliver the performance and security required by highly distributed enterprises. These outdated solutions have become more costly and complicated to implement, install, manage, and maintain.SD-WAN offers unlimited capabilities for accessing the benefits of the cloud and Internet. ...
Deep learning has been very successful in social sciences and specially areas where there is a lot of data. Trading is another field that can be viewed as social science with a lot of data. With the advent of Deep Learning and Big Data technologies for efficient computation, we are finally able to use the same methods in investment management as we would in face recognition or in making chat-bots. In his session at 20th Cloud Expo, Gaurav Chakravorty, co-founder and Head of Strategy Development ...
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory?
Evan Kirstel is an internationally recognized thought leader and social media influencer in IoT (#1 in 2017), Cloud, Data Security (2016), Health Tech (#9 in 2017), Digital Health (#6 in 2016), B2B Marketing (#5 in 2015), AI, Smart Home, Digital (2017), IIoT (#1 in 2017) and Telecom/Wireless/5G. His connections are a "Who's Who" in these technologies, He is in the top 10 most mentioned/re-tweeted by CMOs and CIOs (2016) and have been recently named 5th most influential B2B marketeer in the US. H...